Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
0 %
$ 37.9 M
Market Cap
-0.64
P/E
ANTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ANTX - AN2 Therapeutics, Inc.
85 M
LAST VALUE
4.03%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR